hepat
c
viru
hcv
small
envelop
rna
viru
often
capabl
establish
persist
infect
may
lead
chronic
liver
diseas
cirrhosi
hepatocellular
carcinoma
eventu
death
year
hepat
c
patient
treat
interferonalpha
current
treatment
usual
consist
polyethylen
glycolconjug
combin
ribavirin
even
advanc
ifnbas
therapi
still
ineffect
elimin
viru
larg
proport
individu
therefor
better
understand
ifninduc
innat
immun
respons
urgent
need
use
select
selfrepl
rna
replicon
recent
recombin
fulllength
genom
mani
group
tri
elucid
mechan
ifn
inhibit
hcv
replic
chapter
attempt
summar
current
state
knowledg
interest
field
hcv
research
interferon
ifn
divers
class
cytokin
key
function
innat
immun
respons
virus
review
pestka
et
al
goodbourn
et
al
samuel
three
type
ifn
distinguish
partial
overlap
biolog
properti
type
ifn
secret
virusinfect
cell
highli
special
leukocyt
popul
term
natur
ifnproduc
cell
plasmacytoid
dendrit
cell
colonna
et
al
human
genom
contain
mani
type
ifn
gene
encod
subtyp
reason
human
genom
encod
mani
subtyp
known
specul
differ
subtyp
elicit
slightli
differ
antivir
respons
furthermor
tempt
specul
recent
multipl
gene
consequ
ongo
arm
race
virus
encod
solubl
ifn
receptor
innat
immun
defens
system
type
ifn
gene
differ
ifn
gene
fact
lack
intron
recent
three
distantli
relat
cytokin
identifi
share
sequenc
similar
type
ifn
famili
accordingli
cytokin
name
kotenko
et
al
respect
sheppard
et
al
although
seem
mani
biolog
properti
recent
discov
group
ifnlik
cytokin
resembl
type
ifn
refer
type
iii
ifn
contrast
type
iii
ifn
numer
gene
identifi
human
genom
contain
one
type
ii
ifn
gene
gene
product
express
special
immun
cell
activ
lymphocyt
natur
killer
nk
cell
type
ifn
bind
highli
specif
cell
surfac
receptor
trigger
phosphoryl
nuclear
transloc
famili
latent
transcript
factor
known
signal
transduc
activ
transcript
stat
type
ifn
bind
receptor
ifnar
lead
format
ifnstimul
gene
heterotrim
consist
ifnrespons
activ
gene
transcript
via
ifnstimul
respons
element
isr
type
iii
ifn
bind
differ
receptor
complex
consist
subunit
subunit
donnelli
et
al
nevertheless
trigger
signal
cascad
similar
type
ifn
doyl
et
al
slightli
differ
signal
pathway
describ
type
ii
ifn
bind
receptor
ifngr
lead
phosphoryt
gamma
activ
factor
gaf
phosphoryl
homodim
transloc
nucleu
enhanc
gene
express
bind
gamma
activ
site
ga
besid
wellestablish
signal
pathway
altern
pathway
describ
contribut
antivir
activ
ifn
remain
elucid
pestka
et
al
type
iii
ifn
believ
execut
antivir
activ
induct
protein
accumul
insid
infect
host
cell
effector
protein
may
interfer
distinct
step
viral
replic
trigger
degrad
viral
rna
contrast
predominantli
induc
express
protein
system
function
involv
antigen
process
present
addit
induc
express
releas
chemokin
activ
orchestr
adapt
immun
respons
eg
howev
least
viru
infect
may
also
contribut
establish
antivir
state
induct
protein
direct
antivir
activ
review
guidotti
chisari
note
ifn
test
far
inhibit
hepat
c
viru
hcv
rna
replic
cultur
cell
although
differ
note
respect
ic
kinet
inhibit
hcv
member
genu
hepaciviru
belong
famili
flavivirida
van
regenmortel
et
al
hcv
isol
group
least
genotyp
differ
nucleotid
sequenc
furthermor
within
given
genotyp
subtyp
defin
differ
nucleotid
sequenc
differ
genotyp
show
remark
degre
heterogen
respect
antivir
treatment
mchutchison
fri
exampl
patient
infect
genotyp
mount
sustain
antivir
respons
wherea
infect
genotyp
genotyp
virus
immedi
medic
signific
numer
attempt
made
identifi
viral
factor
determin
outcom
current
ifn
therapi
underli
molecular
mechan
howev
still
controversi
hcv
singlestrand
rna
genom
posit
polar
review
bartenschlag
et
al
genom
encod
larg
polyprotein
coand
posttranscript
cleav
cellular
viral
proteinas
protein
core
product
addit
protein
f
ribosom
frame
shift
report
function
remain
defin
code
sequenc
flank
nontransl
region
ntr
import
rna
translat
ntr
replic
ntr
ntr
highli
structur
contain
numer
stem
loop
notabl
intern
ribosom
entri
site
ire
ntr
honda
et
al
also
region
xtail
sequenc
ntr
blight
rice
furthermor
ntr
sequenc
shown
interact
complementari
code
sequenc
increas
amount
intramolecular
base
pair
kim
et
al
frieb
et
al
figur
show
organ
hcv
genom
depict
key
structur
element
figur
also
summar
major
protein
function
includ
counteract
innat
immun
respons
hcv
replic
take
place
cytoplasm
persist
infect
hepatocyt
princip
host
cell
viru
detail
inform
mode
rna
replic
avail
hcv
analog
flavivirus
westaway
et
al
propos
incom
positivestrand
rna
genom
use
templat
synthesi
negativestrand
rna
molecul
remain
basepair
templat
result
doublestrand
rna
also
call
replic
form
transcrib
multipl
time
result
gener
numer
fulllength
positivestrand
progeni
rna
may
use
replic
translat
packag
newli
form
viru
particl
detail
see
bartenschlag
et
al
doublestrand
rna
form
intramolecular
base
pair
complementari
sequenc
positivestrand
hcv
rna
viral
replic
alert
doublestrand
rna
detect
system
host
cell
would
viru
genom
contain
larg
open
read
frame
orf
encod
major
viral
protein
altern
orf
encod
frame
shift
protein
f
unknown
function
structur
protein
c
liber
polyprotein
cellular
signal
peptidas
cleavag
perform
viral
proteas
rna
secondari
structur
drawn
accord
blight
rice
honda
et
al
et
al
frieb
et
al
black
dot
indic
posit
start
stop
codon
larg
orf
minimum
region
nontransl
region
ntr
requir
replic
initi
translat
encircl
dot
line
rdrp
rnadepend
rna
polymeras
ire
intern
ribosom
entri
site
stem
loop
within
code
sequenc
normal
result
product
type
ifn
subsequ
express
ifninduc
effector
protein
turn
would
establish
antivir
state
ifnproduc
cell
neighbor
cell
hcvinfect
hepatocyt
howev
seem
produc
much
ifn
liver
biopsi
sampl
chronic
hepat
c
patient
lack
detect
amount
type
ifn
mrna
mihm
et
al
find
line
observ
cultur
human
hepatoma
cell
produc
small
amount
ifn
respons
viral
infect
stimuli
poli
inosin
poli
cytosin
c
suggest
human
hepatocyt
gener
rather
poor
ifn
produc
keskinen
et
al
howev
primari
chimpanze
tamarin
hepatocyt
found
highli
respons
poli
poli
c
rais
question
liver
chronic
hepat
c
patient
contain
type
ifn
lanford
et
al
enigma
recent
solv
foy
cowork
report
hcv
proteas
interfer
abil
cell
sens
doublestrand
rna
foy
et
al
cleavag
adaptor
protein
trif
reduc
abund
inhibit
poli
poli
c
activ
signal
tolllik
receptor
pathway
bifurc
nuclear
mediat
gene
activ
pathway
li
et
al
furthermor
cleav
adapt
protein
interrupt
signal
doublestrand
rna
bind
protein
rigi
kinas
phosphoryl
ifn
regulatori
factor
meylan
et
al
act
sabotag
effici
prevent
nuclear
import
latent
transcript
factor
crucial
step
activ
type
ifn
gene
transcript
review
hiscott
et
al
taken
togeth
find
suggest
hcvinfect
hepatocyt
prevent
produc
amount
type
ifn
need
assist
viru
clearanc
nevertheless
type
ifninduc
mrnasprotein
readili
detect
liver
biopsi
hepat
c
patient
even
liver
sampl
contain
detect
amount
type
ifn
mrna
mihm
et
al
beg
question
ifn
local
produc
come
accord
mihm
cowork
natur
ifnproduc
cell
plasmacytoid
dendrit
cell
may
repres
import
extrahepat
sourc
ifn
hepat
c
patient
mihm
et
al
howev
natur
ifnproduc
cell
propens
migrat
secondari
lymphoid
organ
rather
site
inflamm
penna
et
al
consequ
express
type
ifninduc
protein
may
never
reach
level
requir
elimin
viru
alreadi
infect
cell
andor
prevent
infect
new
host
cell
current
licens
hcv
therapi
reli
antivir
activ
type
ifn
mostli
polyethylen
glycolconjug
given
alon
combin
ribavirin
administr
recombin
ifn
bypass
block
ifn
product
hcvinfect
host
cell
dramat
increas
express
type
ifninduc
protein
throughout
bodi
lead
case
rapid
declin
hcv
rna
level
firstphas
respons
believ
reflect
inhibit
viru
replic
later
hcv
rna
level
declin
gradual
secondphas
respons
liver
clear
virusinfect
cell
neumann
et
al
layden
layden
although
initi
reduc
viral
load
almost
patient
sustain
respons
defin
loss
detect
hcv
rna
therapi
continu
absenc
least
month
treatment
end
experienc
patient
especi
patient
suffer
infect
genotyp
virus
often
fail
erad
viru
mann
et
al
fri
et
al
correl
therapi
success
infect
genotyp
suggest
involv
viral
factor
underli
molecular
mechan
yet
understood
develop
hcv
replicon
lohmann
et
al
becam
possibl
analyz
role
individu
cytokin
innat
immun
respons
hcv
patient
respond
least
initi
treatment
unexpect
ifn
type
ifn
also
block
rna
replic
differ
hcv
genotyp
human
hepatoma
cell
blight
et
al
frese
et
al
guo
et
al
cheney
et
al
larkin
et
al
okus
et
al
windisch
et
al
miyamoto
et
al
cell
nonhepat
origin
eg
hela
cell
guo
et
al
cell
ali
et
al
similar
result
obtain
use
type
iii
ifn
robek
et
al
marcello
et
al
cheney
et
al
frese
et
al
antivir
activ
cytokin
frese
et
al
idea
enforc
critic
first
line
defens
hcvinfect
liver
elabor
li
cowork
demonstr
cocultur
experi
nk
cell
block
hcv
replic
cell
secret
li
et
al
clinic
data
limit
still
controversi
discuss
whether
hepat
c
patient
benefit
administr
nevertheless
interest
note
type
ii
ifn
inhibit
hcv
rna
replic
cell
highli
synergist
manner
larkin
et
al
okus
et
al
given
power
combin
therapi
treatment
persist
viru
infect
might
reward
elucid
mechan
respons
observ
synergist
antivir
effect
differ
ifn
type
exampl
enhanc
express
level
one
effector
protein
synergist
manner
suggest
tan
et
al
induc
express
differ
ifn
typespecif
effector
protein
interfer
one
step
hcv
life
cycl
suggest
windisch
et
al
answer
question
may
help
physician
predict
outcom
ifn
therapi
lead
improv
ifnbas
therapi
sever
attempt
made
analyz
systemat
ifninduc
chang
gene
express
hcv
host
cell
one
approach
liver
biopsi
sampl
taken
expetiment
infect
chimpanze
gene
express
profil
monitor
use
cdna
microarray
result
reveal
infect
liver
rapidli
lead
upregul
numer
gene
includ
encod
wellknown
ifninduc
effector
protein
chimpanze
homologu
mxa
bigger
et
al
su
et
al
studi
express
mxa
type
ifninduc
protein
correl
magnitud
durat
infect
howev
transient
sustain
viral
clearanc
rather
associ
product
subsequ
express
type
ii
ifninduc
gene
suggest
biphas
cours
innat
immun
respons
crucial
role
viru
clearanc
anoth
approach
cdna
microarray
use
analyz
ifninduc
chang
gene
express
profil
cultur
human
cell
contain
hcv
replicon
hayashi
et
al
even
similar
studi
lead
identif
effector
protein
inhibit
hcv
replic
ifnstimul
cell
guid
present
futur
investig
suggest
potenti
candid
gene
contribut
promin
ifninduc
effector
protein
figur
ifninduc
inhibit
hcv
replic
discuss
follow
paragraph
antivir
pathway
may
contribut
establish
socal
antivir
state
ifnstimul
human
cell
left
right
mxa
gtpase
inhibit
viral
replic
missort
trap
viral
compon
larg
membraneassoci
complex
role
gtp
hydrolysi
process
fulli
understood
three
differ
ifninduc
oligoadenyl
synthetas
encod
human
genom
bind
doublestrand
rna
dsrna
lead
heteroandor
homooligomer
subsequ
product
oligoadenyl
phosphodiest
bond
linkag
oligonucleotid
activ
latent
endoribonucleas
rnase
l
lead
degrad
viral
cellular
rna
cell
type
express
rnase
l
also
regul
ifn
isoform
adenosin
deaminas
bind
doublestrand
rna
catalyz
convers
adenosin
inosin
edit
may
occur
select
one
posit
frequent
larg
number
site
edit
viral
rna
may
chang
code
sequenc
activ
ispecif
rnase
andor
destroy
rna
secondari
structur
disrupt
adenosineuracil
base
pair
doublestrand
rnaactiv
protein
kinas
pkr
may
block
viral
protein
translat
phosphoryl
therebi
inactiv
eukaryot
initi
factor
furthermor
pkr
may
activ
intracellular
signal
pathway
contribut
establish
robust
antivir
respons
induc
nitric
oxid
synthetas
produc
larg
amount
nitric
oxid
implic
varieti
immun
function
activ
macrophag
mx
protein
belong
superfamili
dynaminlik
larg
gtpase
express
tightli
regul
type
type
iii
ifn
holzing
et
al
review
haller
koch
haller
et
al
two
human
mx
protein
mxa
mxb
mxa
demonstr
antivir
activ
mxa
cytoplasm
protein
size
kda
shown
inhibit
replic
broad
varieti
rna
virus
cell
cultur
experi
demonstr
mxa
inhibit
orthomyxovirus
bunyavirus
rhabdovirus
birnavirus
reovirus
togavirus
mundt
review
haller
et
al
case
viral
replic
almost
complet
block
mxa
exampl
stabli
transfect
vero
cell
constitut
express
mxa
produc
lower
viru
titer
control
cell
express
mx
protein
antivir
effect
mxa
also
analyz
vivo
use
transgen
mice
constitut
express
human
mxa
protein
lack
function
mous
mx
protein
mice
constitut
express
mxa
mount
proper
ifninduc
antivir
respons
due
disrupt
gene
subunit
ifn
type
receptor
case
mxaexpress
anim
found
complet
resist
thogoto
viru
tickborn
orthomyxoviru
hefti
et
al
furthermor
mxaexpress
anim
exhibit
enhanc
resist
influenza
viru
famili
orthomyxovirida
vesicular
stomat
viru
vsv
famili
rhabdovirida
lacross
viru
famili
bunyavirida
semliki
forest
viru
famili
togavirida
hefti
et
al
report
suggest
mxa
even
wider
antivir
activ
support
data
less
convinc
modu
operandi
mxa
complet
understood
accumul
data
indic
cytoplasm
mx
protein
missort
immobil
viral
compon
cell
infect
lacross
viru
mxa
bind
transloc
viral
nucleocapsid
protein
membraneassoci
perinuclear
complex
reichelt
et
al
similar
phenomenon
observ
cell
infect
thogoto
viru
case
howev
mxa
inhibit
nuclear
transport
incom
viral
nucleocapsid
therebi
prevent
primari
transcript
lead
earli
effici
block
viru
replic
healthi
individu
mxa
express
detect
limit
express
level
increas
dramat
mani
viral
infect
consequ
treatment
roer
et
al
chieux
et
al
mxa
mrna
quantif
peripher
blood
mononuclear
cell
even
use
monitor
bioavail
administ
type
ifn
hepat
c
patient
gilli
et
al
jorn
et
al
surprisingli
elev
mxa
express
level
also
found
liver
chronic
hepat
c
patient
indic
ongo
struggl
innat
immun
system
hcv
macquillan
et
al
macquillan
et
al
patzwahl
et
al
genet
studi
japan
address
singl
nucleotid
polymorph
posit
promot
sequenc
mxa
gene
reveal
thymidin
posit
favor
sustain
respons
hepat
c
patient
treatment
wherea
guanosin
g
frequent
found
among
nonrespond
hijikata
et
al
interestingli
posit
increas
homolog
first
isr
mxa
promot
isr
consensu
sequenc
hijikata
et
al
furthermor
experi
report
construct
suggest
allel
higher
transcript
activ
g
allel
stimul
hijikata
et
al
similar
associ
gt
singl
nucleotid
polymorph
posit
mxa
gene
respons
hepat
c
patient
therapi
found
european
studi
genotyp
also
found
associ
abil
clear
hcv
natur
without
help
recombin
ifn
knapp
et
al
sinc
mxa
abil
effici
inhibit
varieti
differ
rna
virus
mxa
first
ifninduc
effector
protein
analyz
antivir
activ
hcv
replicon
system
frese
et
al
howev
evid
found
involv
mxa
ifninduc
inhibit
hcv
rna
replic
constitut
express
mxa
inhibit
subgenom
hcv
replicon
express
dominantneg
mutant
mxa
restor
hcv
rna
replic
treatment
frese
et
al
earlier
observ
line
recent
find
inhibit
hcv
rna
replic
cell
cell
similar
ic
iuml
iuml
respect
although
former
produc
nearli
mxa
mrna
latter
windisch
et
al
taken
togeth
data
indic
inhibit
hcv
rna
replic
mxaindepend
pathway
recent
note
brefeldin
golgi
apparatu
disrupt
agent
render
replic
kunjin
viru
suscept
mxa
hoemen
et
al
sinc
kunjin
viru
hcv
flavivirus
use
host
cellderiv
membran
establish
replic
factori
tempt
specul
whether
disrupt
membran
web
hcvinfect
cell
would
expos
hcv
rnaprotein
complex
antivir
activ
protein
mxa
oasrnas
l
pathway
also
known
ifninduc
respons
requir
two
type
enzym
oligoadenyl
synthetas
ribonucleas
review
samuel
human
genom
contain
four
gene
loci
encod
ifninduc
oligoadenyl
synthetas
oaslik
protein
altern
splice
lead
express
numer
isoform
size
rang
kda
rebouillat
hovanessian
oa
protein
express
enhanc
respons
ifn
magnitud
induct
vari
dramat
differ
ifn
type
produc
cell
newli
produc
oa
protein
believ
inact
bind
doublestrand
rna
lead
oligomer
start
product
oligoadenyl
phosphodiest
bond
linkag
oligonucleotid
oligonucleotid
bind
activ
latent
ribonucleas
rnase
l
process
associ
format
stabl
rnase
l
homodim
activ
rnase
l
degrad
singlestrand
rna
viral
cellular
origin
cleav
target
rna
occur
preferenti
side
uraciladenosin
ua
uu
dinucleotid
floydsmith
et
al
wreschner
et
al
cleavag
mrna
rrna
may
trigger
gener
protein
shutoff
virusinfect
cell
therebi
limit
viru
replic
spread
differ
oa
protein
associ
differ
cellular
compart
vari
respect
amount
doublestrand
rna
need
activ
produc
oligonucleotid
differ
size
samuel
therefor
tempt
specul
divers
oa
protein
isoform
evolv
fight
rather
wide
spectrum
dna
rna
virus
includ
poxvirus
reovirus
picornavirus
member
famili
picornavirida
seem
especi
sensit
oasrnas
l
pathway
exampl
overexpress
form
human
protein
confer
resist
mengoviru
vsv
chebath
et
al
constitut
express
form
protein
inhibit
replic
encephalomyocard
viru
vsv
sendai
viru
reoviru
ghosh
et
al
context
interest
note
one
oa
gene
loci
recent
identifi
confer
increas
resist
west
nile
viru
famili
flavivirida
laboratori
mice
perelygin
et
al
transcript
allel
suscept
mice
contain
prematur
stop
codon
result
truncat
protein
mashimo
et
al
experi
congen
mice
cell
deriv
mice
reveal
express
fulllength
protein
limit
viru
product
vivo
cell
cultur
surprisingli
howev
rnase
l
activ
highest
suscept
cell
downregul
rnase
l
activ
resist
cell
restor
viru
titer
level
observ
suscept
cell
scherbik
et
al
mani
ifninduc
protein
oa
protein
express
slightli
upregul
hepat
c
patient
macquillan
et
al
enhanc
respons
administr
recombin
murashima
et
al
rather
indirect
evid
oasrnas
l
pathway
may
inde
target
hcv
replicationtransl
recent
provid
taguchi
cowork
report
ntermin
portion
amino
acid
lack
socal
pkrbind
domain
bind
oa
protein
counteract
antivir
activ
taguchi
et
al
furthermor
demonstr
purifi
recombin
rnase
l
hela
cell
extract
effici
cleav
hcv
rna
vitro
han
et
al
howev
investig
need
determin
whether
rnase
l
also
cleav
hcv
rna
infect
hcv
host
cell
extent
oasinduc
block
hcv
protein
translat
contribut
ifninduc
inhibit
hcv
rna
replic
form
togeth
less
extens
studi
protein
small
famili
constitut
express
adenosin
deaminas
act
rna
review
valent
nishikura
toth
et
al
bind
highli
structur
rna
catalyz
hydrolyt
deamin
adenosin
reaction
convert
adenosin
inosin
edit
adarmedi
edit
may
occur
select
one
posit
frequent
larger
number
site
hyperedit
hypermut
exchang
may
sever
consequ
edit
code
sequenc
may
lead
amino
acid
exchang
recogn
g
translat
machineri
note
edit
creat
stop
codon
edit
noncod
region
may
affect
rna
splice
stabil
translat
effici
eg
disrupt
au
base
pair
edit
may
regul
gene
silenc
eg
disrupt
au
base
pair
hyperedit
rna
may
recogn
cleav
ispecif
rnase
scadden
smith
promin
exampl
cellular
rna
edit
adar
protein
mrna
propion
ampa
receptor
subunit
edit
codon
exon
result
amino
acid
exchang
chang
ca
permeabl
receptor
highli
specif
edit
event
farreach
consequ
knockout
mice
prone
seizur
die
young
impair
phenotyp
appear
result
entir
singl
underedit
posit
mrna
revert
normal
allel
underedit
transcript
substitut
allel
encod
edit
version
exon
higuchi
et
al
likewis
genet
target
locu
reveal
essenti
requir
adar
protein
embryogenesi
mice
wang
et
al
wang
et
al
hartner
et
al
suggest
express
protect
stressinduc
apoptosi
wang
et
al
closer
look
gene
locu
reveal
protein
express
control
three
promot
altern
splice
review
toth
et
al
two
constitut
activ
promot
drive
express
protein
wherea
ifnregul
promot
isr
control
express
larger
isoform
express
respons
inflamm
ifn
treatment
patterson
samuel
georg
samuel
yang
et
al
yang
et
al
isoform
contain
multipl
nuclear
local
signal
ifninduc
isoform
nuclear
export
signal
accordingli
nuclear
protein
detect
nuclear
cytoplasm
compart
hypermut
viral
rna
observ
sever
rna
virus
includ
measl
viru
parainfluenza
viru
famili
paramyxovirida
vsv
ohara
et
al
cattaneo
et
al
murphi
et
al
specul
subacut
scleros
panenceph
sspe
fatal
necropath
respons
patient
persist
measl
viru
infect
brain
associ
extens
edit
matrix
protein
mrna
prevent
virion
assembl
releas
step
viral
life
cycl
requir
function
matrix
protein
transcript
howev
less
frequent
edit
thought
result
persist
viru
replic
cattaneo
et
al
baczko
et
al
thu
incomplet
adarmedi
innat
immun
respons
might
contribut
patholog
sspe
interestingli
certain
virus
abus
adar
protein
control
import
checkpoint
replic
particl
format
wellknown
exampl
hepat
viru
hdv
subvir
human
pathogen
depend
hepat
b
viru
helper
viru
review
casey
hdv
small
circular
rna
genom
encod
singl
protein
hepat
delta
antigen
hdag
without
edit
acid
version
hdag
made
essenti
viru
replic
kuo
et
al
later
viral
life
cycl
highli
specif
edit
event
chang
uag
amber
stop
codon
uig
tryptophan
codon
acid
hdagl
produc
mediat
genom
packag
chang
et
al
hcv
rna
may
also
subject
adarmedi
modif
case
edit
seem
less
specif
inhibit
viru
replic
recent
report
silenc
express
hcv
replicon
cell
increas
amount
hcv
rna
moreov
taylor
cowork
note
increas
frequenc
g
mutat
subgenom
replicon
rna
transfect
adarspecif
sirna
rescu
hcv
rna
replic
presenc
moder
concentr
base
find
taylor
et
al
conclud
inhibit
hcv
replic
adarmedi
hyperedit
viral
rna
laboratori
use
specif
antibodi
determin
intracellular
local
anddespit
nuclear
export
signal
observ
accumul
predominantli
nucleu
ifntreat
cell
presenc
subgenom
fulllength
hcv
rna
howev
observ
local
distinct
cytoplasm
structur
e
dazert
r
bartenschlag
frese
unpublish
result
also
analyz
antivir
effect
constitut
express
hcv
replic
found
overexpress
cell
block
hcv
rna
replic
taken
togeth
find
support
idea
taylor
et
al
interact
hcv
rna
argu
context
ifninduc
protein
studi
way
fulli
elucid
role
ifninduc
inhibit
hcv
replic
anoth
promin
protein
innat
immun
defens
long
suspect
interf
hcv
replic
doublestrand
rnaactiv
protein
kinas
pkr
serinethreonin
kinas
constitut
express
multipl
function
control
host
cell
transcript
translat
review
garcia
et
al
upon
stimul
ifn
cell
respond
increas
express
pkr
ifninduc
pkr
accumul
cytoplasm
found
associ
ribosom
thomi
et
al
pkr
may
exert
antivir
activ
differ
pathway
review
toth
et
al
first
pkr
abl
control
cellular
translat
machineri
phosphoryl
subunit
eukaryot
translat
initi
factor
would
affect
product
host
viru
protein
second
pkrmediat
phosphoryl
implic
sever
signal
pathway
contribut
establish
robust
antivir
respons
exampl
pkr
shown
activ
latent
transcript
factor
may
lead
enhanc
express
proinflammatori
gene
gil
et
al
addit
pkr
may
activ
kinas
mitogenactiv
protein
map
kinas
intensifi
diversifi
innat
immun
respons
goh
et
al
concept
pkrmediat
phosphoryl
event
play
import
role
innat
immun
respons
viral
infect
larg
base
fact
mani
rna
dna
virus
tri
inhibit
pkr
overexpress
small
rna
bind
activ
pkr
produc
decoy
enhanc
pkr
degrad
review
langland
et
al
pkr
key
player
ifninduc
antivir
defens
genet
target
knockout
mice
lack
function
pkr
protein
extrem
sensit
viral
infect
two
line
pkr
mice
gener
code
sequenc
either
ntermin
ctermin
part
protein
disrupt
yang
et
al
abraham
et
al
respect
pkr
mice
inde
suscept
certain
viru
infect
wildtyp
anim
balachandran
et
al
stojdl
et
al
carr
et
al
samuel
et
al
least
case
seem
depend
mous
strain
use
experiment
condit
murphi
et
al
addit
experi
conduct
use
mef
pkr
mice
direct
antivir
activ
pkr
eg
inhibit
viru
multipl
block
protein
translat
still
controversi
interestingli
prime
pkr
mice
poli
poli
c
ifn
viru
challeng
point
rather
indirect
mode
pkr
action
enhanc
doublestrand
rnainduc
signal
event
yang
et
al
howev
note
experi
perform
virus
encod
pkr
inhibitor
would
interest
reevalu
phenotyp
pkr
mice
genet
modifi
virus
express
function
pkr
inhibitor
anoth
problem
character
pkr
mice
presenc
relat
kinas
also
phosphoryl
toth
et
al
even
kinas
differ
pkr
respons
doublestrand
rna
andor
physiolog
stress
signal
may
partial
substitut
lack
pkr
pkr
mice
therebi
make
difficult
quantifi
contribut
pkr
innat
immun
respons
exemplifi
smith
et
al
two
hcv
protein
describ
interact
kinas
analyz
hcv
sequenc
japanes
hepat
c
patient
mutat
within
discret
region
socal
ifn
sensit
determin
region
isdr
propos
confer
resist
enomoto
et
al
enomoto
et
al
sinc
origin
report
enomoto
cowork
numer
studi
conduct
japan
well
countri
determin
predict
valu
sequenc
outcom
ifnbas
therapi
exist
isdr
still
controversi
review
tan
katz
reinvestig
pascu
et
al
brillet
et
al
whether
isdr
realli
exist
descript
sequenc
put
focu
hcv
research
subsequ
find
mutat
isdr
affect
abil
bind
inhibit
pkr
gale
et
al
led
hypothesi
pkr
block
hcv
replic
abl
counteract
antivir
activ
pkr
howev
experi
hcv
replicon
provid
evid
involv
ifn
resist
contrari
point
mutat
within
isdr
delet
amino
acid
encompass
entir
isdr
enhanc
viral
replic
without
affect
ifn
sensit
hcv
replicon
blight
et
al
guo
et
al
find
extend
kaul
r
bartenschlag
analyz
function
use
two
subgenom
genotyp
replicon
differ
code
sequenc
one
replicon
isdr
ident
ifnsuscept
strain
wherea
isdr
sequenc
replicon
contain
mutat
suspect
confer
pkr
bind
ifn
resist
gale
et
al
despit
differ
replicon
found
equal
sensit
unpublish
result
result
argu
hypothesi
counteract
ifninduc
pkrmediat
block
viral
protein
translat
howev
result
contradict
idea
inhibit
activ
pkr
eg
pkrmediat
prime
intracellular
signal
pathway
note
sever
report
suggest
may
sabotag
innat
immun
respons
pkrindepend
activ
discuss
macdonald
harri
exampl
report
increas
product
interleukin
il
therebi
attenu
antivir
properti
ifn
polyak
et
al
polyak
et
al
would
interest
studi
immunomodulatori
activ
immunocompet
small
anim
model
might
final
put
end
discuss
role
pkr
hcv
patholog
second
hcv
protein
report
interact
pkr
found
bind
pkr
homolog
domain
pephd
taylor
et
al
taylor
et
al
pavio
et
al
howev
signific
observ
question
increas
number
clinic
studi
demonstr
pephd
highli
conserv
region
conspicu
mutat
accumul
therapi
review
tan
katz
furthermor
express
increas
resist
hcv
genotyp
replicon
toward
ifn
genom
replicon
encod
protein
pephd
sequenc
resist
hcv
isol
similar
degre
suscept
subgenom
replicon
lack
frese
et
al
kaul
r
bartenschlag
unpublish
result
adenovirusassoci
rna
va
small
highli
structur
rna
bind
pkr
trigger
dimer
activ
recent
found
stimul
hcv
rna
replic
replicon
system
also
report
recombin
va
rna
effici
rescu
hcv
rna
replic
presenc
much
iuml
sinc
va
rna
may
also
bind
protein
innat
immun
respons
research
need
defin
role
pkr
limit
hcv
protein
translat
direct
approach
question
pkr
interfer
hcv
rna
replicationtransl
recent
undertaken
use
rna
silenc
kaul
r
bartenschlag
transfect
cell
contain
subgenom
hcv
replicon
sirna
target
pkr
mrna
degrad
subsequ
treat
cell
differ
concentr
case
observ
downregul
pkr
express
level
result
restor
hcv
replic
presenc
ifn
unpublish
result
establish
new
gener
hcv
replicon
contain
consensu
sequenc
japanes
genotyp
isol
replic
effici
without
need
adapt
mutat
becam
possibl
studi
hcv
rna
replic
varieti
new
host
cell
includ
nonhepat
nonhuman
origin
kato
et
al
uprichard
et
al
recent
genotyp
replicon
employ
chang
cowork
set
analyz
antivir
effect
type
ifn
hcv
replic
mef
pkr
mice
congen
wildtyp
mice
interestingli
well
inhibit
hcv
rna
replic
pkr
mef
effici
pkr
mef
chang
et
al
suggest
pkrmediat
translat
control
play
minor
role
ifninduc
inhibit
hcv
rna
replic
induc
nitric
oxid
synthetas
origin
name
ino
also
abbrevi
belong
small
famili
noproduc
enzym
unstimul
cell
virtual
absent
express
level
increas
rapidli
respons
proinflammatori
cytokin
especi
express
result
longlast
product
karupiah
et
al
free
radic
recogn
strong
antimicrobi
activ
variou
protozoa
bacteria
virus
exampl
replic
coxsackieviru
suppress
inactiv
viral
cystein
proteas
snitrosyl
saura
et
al
furthermor
product
essenti
cellmedi
noncytopath
inhibit
hepat
b
viru
replic
virustransgen
mice
guidotti
et
al
virus
report
sensit
includ
sever
acut
respiratori
coronaviru
akerstrom
et
al
respiratori
syncyti
viru
stark
et
al
mous
hepat
viru
pope
et
al
herp
simplex
viru
type
adler
et
al
howev
use
infect
host
antimicrobi
substanc
doubleedg
sword
noinduc
oxid
stress
may
caus
sever
cellular
organ
dysfunct
influenza
virusinfect
wildtyp
mice
exampl
suffer
excess
product
lung
often
lead
respiratori
failur
death
wherea
knockout
mice
express
function
surviv
infect
littl
evid
pneumon
akaik
et
al
karupiah
et
al
liver
hcvinfect
individu
easili
detect
mihm
et
al
majano
et
al
schweyer
et
al
enhanc
express
liver
hepat
c
patient
larg
attribut
releas
resid
infiltr
immun
cell
addit
specul
hcv
replic
may
stimul
express
infect
hepatocyt
machida
et
al
base
genet
studi
suggest
product
involv
hcv
clearanc
certain
haplotyp
frequent
found
among
hcvinfect
individu
spontan
clear
infect
ifntreat
hepat
c
patient
could
mount
sustain
antivir
respons
yee
et
al
hypothesi
howev
lack
support
evid
cell
cultur
experi
treatment
cell
donor
z
aminoethyl
n
amino
deta
nonoat
arginas
inhibitor
nghydroxylarginin
noha
result
inhibit
hcv
rna
replic
frese
et
al
furthermor
no
inhibitor
lysin
lnil
even
partial
restor
hcv
replic
presenc
frese
et
al
one
howev
overinterpret
result
vivo
product
may
complex
consequ
could
investig
cell
cultur
may
act
messeng
rather
effector
molecul
may
induc
dna
damag
apoptosi
jaiswal
et
al
thu
studi
need
fulli
elucid
role
hepat
c
patholog
far
ifninduc
effector
protein
investig
respect
potenti
inhibit
hcv
rna
replic
notabl
indoleamin
ido
idomedi
deplet
tryptophan
well
known
defens
mechan
certain
intracellular
parasit
carlin
et
al
rather
recent
pathway
also
recogn
antivir
defens
mechan
herpesvirus
bodaghi
et
al
poxvirus
terajima
leporati
ido
inhibit
hcv
replic
well
inhibit
effector
protein
addit
tryptophan
cell
cultur
medium
restor
viral
protein
synthesi
howev
ido
inhibitor
restor
replic
subgenom
hcv
replicon
presenc
frese
et
al
likewis
increas
concentr
ltryptophan
could
rescu
viral
protein
synthesi
frese
et
al
suggest
deplet
tryptophan
notor
onlymechan
inhibit
replic
hcv
rna
besid
induct
direct
antivir
activ
infect
host
cell
ifn
may
enhanc
direct
activ
nk
cell
cell
indirect
effect
usual
ascrib
shin
cowork
note
type
ifn
also
stimul
gener
immunoproteasom
liver
hepat
c
patient
shin
et
al
would
interest
determin
extent
indirect
effect
contribut
antivir
activ
type
ifn
